In recent years, the keywords of interest included “p53”, “expression”, “multicenter”, “open trial”, “preoperative radiotherapy”, and “postoperative radiotherapy”, which indicate that mechanistic studies, clinical trials, and neoadjuvant/adjuvant radiotherapy studies may be the recent hotspots in the field of rectal cancer. Here, TP53 is linked to rectal cancer.